Offices:
Espoo
Investors:
we tracked 5 investors
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Total investments received (USD) - we tracked 2 transactions
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergen immunotherapy products that are based on switching the immune system's response to allergens from hypersensitivity to tolerance.
We have a unique approach for designing the hypoallergens used in immunotherapy. By studying the molecular mechanism of the hypersensitivity reaction, we have made discoveries that allow for improved design of immunotherapeutic products against common types of allergies.
Our goal is to provide long-term relief for patients suffering from allergic symptoms, as well as reduce the social and economic burden allergies cause to both individuals and society.
Companies with similar profile to Desentum:
Company | Criteria |
BioMensio45% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: VTT Ventures
- Minim one investor from outside Scandinavia: Yes
|
Minima Processor44% | - Similar business models: B2B
- At least one vc investor: VTT Ventures
- Total raised in a similar range: 5M - 10M USD
- Minim one investor from outside Scandinavia: Yes
|
LymphaTouch44% | - Similar business models: B2B
- At least one vc investor: ACME Investments
- Total raised in a similar range: 5M - 10M USD
- Minim one investor from outside Scandinavia: Yes
|
Gradientech44% | - Similar verticals: Biotech, Pharma
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
|
Asqella44% | - Similar business models: B2B
- At least one vc investor: VTT Ventures
- Total raised in a similar range: 5M - 10M USD
- Minim one investor from outside Scandinavia: Yes
|
OxThera44% | - Similar verticals: Biotech, Pharma
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
Cirqle Biomedical44% | - Similar verticals: Biotech, Pharma
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
Aiforia44% | - Similar business models: B2B
- At least one vc investor: ACME Investments, Sto-Rahoitus Oy
- Total raised in a similar range: 5M - 10M USD
- Minim one investor from outside Scandinavia: Yes
|
AFYX Therapeutics44% | - Similar verticals: Biotech, Pharma
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
STipe Therapeutics44% | - Similar verticals: Biotech, Pharma
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
NMD Pharma44% | - Similar verticals: Biotech, Pharma
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
ITBMed44% | - Similar verticals: Biotech, Pharma
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
Mobidiag43% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one other investor: Springvest Oy
- Minim one investor from outside Scandinavia: Yes
|
Biosyntia43% | - Similar verticals: Biotech
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
- Minim one investor from outside Scandinavia: Yes
|
CysBio43% | - Similar verticals: Biotech
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
- Minim one investor from outside Scandinavia: Yes
|
Sorbwater Technology43% | - Similar verticals: Biotech
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
- Minim one investor from outside Scandinavia: Yes
|
Monocl43% | - Similar verticals: Biotech
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
- Minim one investor from outside Scandinavia: Yes
|
Solar Foods35% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: VTT Ventures
|
Quretech Bio34% | - Similar verticals: Biotech, Pharma
- Similar business models: B2B
|
Athera34% | - Similar verticals: Biotech, Pharma
- Similar business models: B2B
|